
|Articles|June 1, 2002
Terbinafine shows dose-dependency in tinea capitis
New Orleans - Dose rather than duration of therapy appears to be the important factor for achieving favorable cure rates using oral terbinafine (Lamisil) for the treatment of tinea capitis, Sheila Fallon Friedlander, M.D., said at the annual meeting of the American Academy of Dermatology.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Top 5 Articles of the Week: November 30-December 5
3
The Weekly Roundup: December 1-5
4
ICYMI: First Patient Dosed in Global Phase 2 Study of Oral TYK2 Inhibitor Soficitinib for PN
5



















